4.7 Article

A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell & Tissue Engineering

Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders

Jack T. Whiteley et al.

Summary: Recent advances in genetics, molecular biology, and stem cell biology have accelerated our understanding of neuropsychiatric disorders. This progress highlights the complexity of the human brain and mental illnesses at the biochemical and cellular level, and discusses the application of tools like CRISPR-Cas9 in developing models.

STEM CELL REPORTS (2022)

Article Cell & Tissue Engineering

Generation of human induced pluripotent stem cell lines derived from four DiGeorge syndrome patients with 22q11.2 deletion

Tomoya Shimizu et al.

Summary: This study successfully generated DiGeorge syndrome-specific hiPSCs and demonstrated their self-renewal and pluripotency. As the molecular pathogenesis of DiGeorge syndrome is largely unknown, these cell resources will be valuable for recapitulating disease phenotypes and developing new therapies.

STEM CELL RESEARCH (2022)

Article Multidisciplinary Sciences

The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia

Ralda Nehme et al.

Summary: The mechanism by which the 22q11.2 deletion predisposes to psychiatric disease is not well understood. In this study, the authors investigated human neuronal cells and found that the deletion regulates the expression of genes associated with autism, schizophrenia, and synaptic biology. Using induced pluripotent stem cells and CRISPR/Cas9 technology, the researchers found that the deletion alters the abundance of transcripts associated with neurodevelopmental disorders during differentiation into neural progenitor cells. Furthermore, the altered transcripts in excitatory neurons were found to encode presynaptic factors and were associated with genetic risk for schizophrenia.

NATURE COMMUNICATIONS (2022)

Article Oncology

Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL

Matthew A. Nix et al.

Summary: CD72 is identified as a potential target for MLLr B-ALL and other B-cell malignancies, and nanobody CAR-T cells have been developed to target CD72 with promising efficacy, providing a new strategy for patients with poor prognoses in B-cell malignancy relapsing after CD19-targeted immunotherapy.

CANCER DISCOVERY (2021)

Article Biochemistry & Molecular Biology

Cell-Surface Proteomic Profiling in the Fly Brain Uncovers Wiring Regulators

Jiefu Li et al.

Article Biochemistry & Molecular Biology

Neuronal defects in a human cellular model of 22q11.2 deletion syndrome

Themasap A. Khan et al.

NATURE MEDICINE (2020)

Article Cell & Tissue Engineering

The in vivo timeline of differentiation of engrafted human neural progenitor cells

Stefanie Vogel et al.

STEM CELL RESEARCH (2019)

Review Genetics & Heredity

Human Models Are Needed for Studying Human Neurodevelopmental Disorders

Xinyu Zhao et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2018)

Review Genetics & Heredity

Molecular genetics of 22q11.2 deletion syndrome

Bernice E. Morrow et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)

Article Multidisciplinary Sciences

In vivo modeling of human neuron dynamics and Down syndrome

Raquel Real et al.

SCIENCE (2018)

Article Medicine, General & Internal

Genetic Drivers of Kidney Defects in the DiGeorge Syndrome

E. Lopez-Rivera et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cell & Tissue Engineering

CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs

Mohammad A. Mandegar et al.

CELL STEM CELL (2016)

Article Biochemical Research Methods

The Perseus computational platform for comprehensive analysis of (prote)omics data

Stefka Tyanova et al.

NATURE METHODS (2016)

Article Biochemical Research Methods

The MaxQuant computational platform for mass spectrometry-based shotgun proteomics

Stefka Tyanova et al.

NATURE PROTOCOLS (2016)

Article Psychiatry

Analysis of induced pluripotent stem cells carrying 22q11.2 deletion

M. Toyoshima et al.

TRANSLATIONAL PSYCHIATRY (2016)

Article Clinical Neurology

Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms

Alina Guna et al.

JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2015)

Article Medicine, General & Internal

22q11.2 deletion syndrome

Donna M. McDonald-McGinn et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Article Biochemical Research Methods

Isolation of single-base genome-edited human iPS cells without antibiotic selection

Yuichiro Miyaoka et al.

NATURE METHODS (2014)

Article Psychiatry

Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome

Stephen Monks et al.

SCHIZOPHRENIA RESEARCH (2014)

Article Developmental Biology

The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disorders

Liam J. Drew et al.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2011)

Article Biotechnology & Applied Microbiology

Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins

Bernd Wollscheid et al.

NATURE BIOTECHNOLOGY (2009)

Article Multidisciplinary Sciences

Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome

Daniel W. Meechan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Psychology, Developmental

The 22q11.2 deletion in children: High rate of autistic disorders and early onset of psychotic symptoms

Jacob A. S. Vorstman et al.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)

Article Biotechnology & Applied Microbiology

In vitro differentiation of transplantable neural precursors from human embryonic stem cells

SC Zhang et al.

NATURE BIOTECHNOLOGY (2001)